Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCOG trial of rivaroxaban versus warfarin on cognition in older adults with non-valvular atrial fibrillation
2019-000794-23Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) comparing Rivaroxaban arm with Warfarin arm (2 arms). Primary endpoint: Change in global cognitive performance at 52 weeks. Started May 2019; status: terminated.
02
Drugs
rivaroxabanwarfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2019-000794-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000794-23.